Bibliographic Details
| Title: |
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy. |
| Authors: |
Wilcox KS; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, USA. Electronic address: karen.wilcox@hsc.utah.edu., West PJ; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, USA. Electronic address: peter.west@utah.edu., Metcalf CS; Anticonvulsant Drug Development (ADD) Program, Department of Pharmacology & Toxicology, University of Utah, USA. Electronic address: cameron.s.metcalf@utah.edu. |
| Source: |
Neuropharmacology [Neuropharmacology] 2020 Apr; Vol. 166, pp. 107811. Date of Electronic Publication: 2019 Nov 30. |
| Publication Type: |
Journal Article; Research Support, N.I.H., Extramural; Review |
| Journal Info: |
Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
